Why MBX Biosciences, Inc.’s (MBX) Stock Is Up 5.89%
As of Tuesday, November 10, MBX Biosciences, Inc.’s MBX share price has surged by 5.89%, which has investors questioning if this is right time to sell.Tudor Pop
A+ Stock Grade Summary:
| VALUE: |
|
|
| GROWTH: |
|
|
| MOMENTUM: |
|
|
| EPS REVISIONS: |
|
|
| QUALITY: |
|
|
Tudor Pop
Rosalio Madrigal
Cynthia McLaughlin
Jenna Brashear
Cynthia McLaughlin
| Share Statistics | MBX | Industry Median |
Percentile (All Stocks) |
|
| Market Cap (Mil) | $2,652.1 | $403.8 | 59% |
|
| Shares Out (Mil) | 48.6 | 47.2 | 47% |
|
| Institutional Ownership | 96.7% | 82.0% | 70% |
|
| Float (Mil) | 31.2 | 49.0 | 36% |
|
| Beta | 0.18 | 0.68 | 11% |
|
| Avg Daily Volume (000s) | 623 | 347 | 61% |
|
| Price Change (52-week) |
102.6% | 51.1% | 96% |
|
| Growth | MBX | Industry Median |
Percentile (All Stocks) |
|
| Sales (5yr) | na | 6.6% | na |
|
| Net Income (5yr) | na | (1.4%) | na |
|
| EPS (5yr) | na | 15.1% | na |
|
| Dividends (5yr) | na | 0.0% | na |
|
| Cash Flow (5yr) | na | (15.1%) | na |
|
| Estimates | Qtrly | Current Fiscal Year |
Next Fiscal Year |
|
| # of Estimates | 7 | 7 | 8 | |
| Current EPS | ($0.929) | ($3.476) | ($4.354) | |
| Month Ago EPS | ($0.931) | ($3.054) | ($3.976) | |
| # Rev Up | 0 | 0 | 0 | |
| # Rev Down | 1 | 1 | 1 | |
| Three Months Ago EPS | ($0.931) | ($3.108) | ($3.942) | |
| Year/Year Chg | (27.7%) | 45.9% | 128.1% | |
| Financials | MBX | Industry Median |
Percentile (All Stocks) |
|
| Sales (TTM) (Mil) | na | $275 | na |
|
| Net Income (TTM) (Mil) | ($145) | ($11) | 8% |
|
| EPS (TTM) | ($3.090) | ($0.600) | 11% |
|
| Operating Cash Flow (TTM) (Mil) | ($96) | ($7) | 6% |
|
| Net Cash Flow (TTM) (Mil) | ($61) | $1 | 19% |
|
| Long-Term Debt (Q1) (Mil) | $3 | $4 | 21% |
|
| Enterprise Value (Q1) (Mil) | $2,319 | $373 | 51% |
|
| Valuation | MBX | Industry Median |
Percentile (All Stocks) |
|
| P/B | 5.60 | 2.20 | 84% |
|
| P/E | na | 21.1 | na |
|
| Dividend Yield | na | 0.0% | na |
|
| PEG (5yr hist) | na | 1.1 | na |
|
| Ratios | MBX | Industry Median |
Percentile (All Stocks) |
|
| Gross Margin | na | 69.4% | na |
|
| Net Margin | na | 3.5% | na |
|
| ROA | (32.2%) | (24.6%) | 15% |
|
| ROE | (33.7%) | (24.4%) | 19% |
|
| Liabilities to Assets | 5.5% | 32.0% | 3% |
|
| F-Score | 1 | 3 | 1% |
|
Passing Stock Screens
As of 11/19/2026, from a list of 60 stock screening strategies,
| Performance Since Inception: | 2.8% |
| +/- S&P 500: | -4.6 |
| Performance Since Inception: | 2.1% |
| +/- S&P 500: | -5.3 |
Price and market data provided by QuoteMedia and delayed a minimum of 15 minutes unless otherwise indicated. Fundamental data provided by AAII's Stock Investor Pro and S&P Global Market Intelligence and are updated through the previous trading day.
Ⓒ 2026 American Association of Individual Investors